


Clinically Relevant Models
Our PD models faithfully replicate key pathological features of Parkinson's disease, including dopaminergic neuron degeneration in the substantia nigra, decreased dopamine secretion in the striatum, and α-synuclein aggregation — providing clinically predictive platforms for drug efficacy evaluation.
01

Comprehensive Assessment
We offer a full spectrum of behavioral and biochemical assessments — rotarod, grip strength, gait analysis, neurochemical analysis, and histopathology — to comprehensively characterize drug effects across all PD models.
02

Customizable Study Design
From model selection to experimental endpoints, our team works closely with sponsors to tailor study protocols that align with specific research goals and regulatory requirements for Parkinson's disease therapies.
03
Discover related models and services to accelerate your cardiovascular research

Let us know which event you're attending and we'd be happy to connect with you.